2796
Pharmarise Holdings Corporation
ファーマライズホールディングス
- Industry
- Retail Trade
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
May 2021
52,324
May 2022
51,608
May 2023
52,030
May 2024
54,466
May 2025
63,508
Operating profit(million JPY)
May 2021
1,246
May 2022
1,520
May 2023
1,438
May 2024
916
May 2025
293
Operating profit margin(%)
May 2021
2.38
May 2022
2.95
May 2023
2.76
May 2024
1.68
May 2025
0.46
Profit before tax(million JPY)
May 2021
1,202
May 2022
1,322
May 2023
1,049
May 2024
143
May 2025
8
Profit(million JPY)
May 2021
426
May 2022
447
May 2023
333
May 2024
-351
May 2025
-367
Total assets(million JPY)
May 2021
24,724
May 2022
23,746
May 2023
23,421
May 2024
29,486
May 2025
31,924
Cash and cash equivalents(million JPY)
May 2021
4,604
May 2022
3,991
May 2023
4,734
May 2024
7,100
May 2025
4,891
Cash flows from operating activities(million JPY)
May 2021
1,945
May 2022
713
May 2023
2,520
May 2024
2,714
May 2025
1,311
Cash flows from investing activities(million JPY)
May 2021
-1,076
May 2022
-292
May 2023
-703
May 2024
-3,120
May 2025
-4,462
Cash flows from financing activities(million JPY)
May 2021
-728
May 2022
-1,034
May 2023
-1,072
May 2024
2,771
May 2025
939
Return on equity(%)
May 2021
7.3
May 2022
7.2
May 2023
5.1
May 2024
-5.1
May 2025
-5.3
Equity ratio(%)
May 2021
24.3
May 2022
26.9
May 2023
28.5
May 2024
24.3
May 2025
20.9
Earnings per share(JPY per share)
May 2021
45.83
May 2022
47.99
May 2023
35.45
May 2024
-33.41
May 2025
-32.48
Net assets per share(JPY per share)
May 2021
646.66
May 2022
684.2
May 2023
708.01
May 2024
636.25
May 2025
586.21
Dividend per share(JPY per share)
May 2021
14
May 2022
14
May 2023
14
May 2024
20
May 2025
14
Payout ratio(%)
May 2021
30.55
May 2022
29.17
May 2023
39.49
May 2024
-
May 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.